×
For best experience we recommend to activate Javascript in your browser.
CTHRC1 antibody (AA 31-243)
This anti-CTHRC1 antibody is a Rabbit Polyclonal antibody detecting CTHRC1 in WB, IHC, IP and ICC. Suitable for Human.
Quick Overview for CTHRC1 antibody (AA 31-243) (ABIN7614831)
Target
See all CTHRC1 Antibodies
CTHRC1
(Collagen Triple Helix Repeat Containing 1 (CTHRC1))
Reactivity
All reactivities for CTHRC1 antibodies
Human
Host
All hosts for CTHRC1 antibodies
Rabbit
Clonality
All clonalities for CTHRC1 antibodies
Polyclonal
Conjugate
All conjugates for CTHRC1 antibodies
This CTHRC1 antibody is un-conjugated
Application
All applications for CTHRC1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CTHRC1 Antibody
(hide)
Binding Specificity
All epitopes for CTHRC1 antibodies
AA 31-243
Purpose
Collagen Triple Helix Repeat Containing Protein 1 (CTHRC1) Polyclonal Antibody
Sequence
Ser31~Lys243
Characteristics
The Collagen Triple Helix Repeat Containing Protein 1 (CTHRC1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CTHRC1
(hide)
Target
CTHRC1
(Collagen Triple Helix Repeat Containing 1 (CTHRC1))
Alternative Name
CTHRC1
Gene ID
115908
UniProt
Q96CG8
Pathways
Tube Formation
Recently viewed
(hide)
Chat with us , powered by LiveChat